Iscover (Clopidogrel)

Clopidogrel irreversibly blocks the platelet P2Y12 ADP receptor, preventing ADP‑mediated activation of the GPIIb/IIIa complex. This stops platelets from aggregating and forming arterial clots, thereby reducing the likelihood of heart attacks, strokes, and other vascular occlusions.

The dose of Iscover is determined by the prescribing clinician based on the individual’s clinical condition, renal function, and concomitant therapies. Standard dosing regimens exist in clinical guidelines, but the exact amount and frequency must be set by a qualified health‑care professional.

Safety data for clopidogrel in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified health‑care provider.

To order Iscover, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The most common alternative to clopidogrel is aspirin or the newer P2Y12 inhibitor ticagrelor. Aspirin has a shorter half‑life and a different bleeding profile, while ticagrelor provides more rapid and reversible platelet inhibition but may be associated with higher rates of dyspnea. Choice depends on patient risk factors and physician judgment.

Iscover should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposure to extreme temperatures or humidity, which could affect tablet integrity.

Iscover is taken orally, usually as a whole tablet swallowed with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to maintain consistent absorption.

The most serious risks include severe or life‑threatening bleeding such as intracranial hemorrhage, gastrointestinal bleeding, and rare cases of thrombocytopenia. Patients should seek immediate medical attention if they notice unusual bruising, blood in stool or urine, severe headache, or any signs of an allergic reaction.

Iscover is contraindicated in patients with active pathological bleeding, a history of severe hypersensitivity to clopidogrel or any component of the formulation, and in those with severe liver disease where platelet function is markedly impaired. Clinicians must also evaluate risk in patients with recent major surgery or uncontrolled hypertension.